ASX - By Stock
|
ME1 |
Re:
Ann: ME1 Q1 FY24 Revenue
|
|
followmemax
|
106 |
18K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
106
|
18K
|
6
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Mernova New Purchase Orders Update
|
|
followmemax
|
14 |
4.8K |
3 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
14
|
4.8K
|
3
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Proposed issue of securities - ME1
|
|
followmemax
|
14 |
6.4K |
2 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
14
|
6.4K
|
2
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Record Revenue Quarter With Group Sales Up 105%
|
|
followmemax
|
45 |
19K |
1 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
45
|
19K
|
1
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Health House International Revenue Update
|
|
followmemax
|
22 |
7.1K |
4 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
22
|
7.1K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Mernova - Q1 Cashflow Positive With Record Revenues
|
|
followmemax
|
13 |
6.9K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
13
|
6.9K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Censure of Creso Pharma Limited
|
|
followmemax
|
28 |
16K |
1 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
28
|
16K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: $2.5M Con Note Issue, Rollover & Extinguishment of Debt
|
|
followmemax
|
29 |
13K |
1 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
29
|
13K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Top 20 securityholders
|
|
followmemax
|
17 |
4.7K |
2 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
17
|
4.7K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Top 20 securityholders
|
|
followmemax
|
17 |
4.7K |
1 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
17
|
4.7K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: La Plata Debt Restructure & Abby and Finn LOI
|
|
followmemax
|
18 |
7.2K |
1 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
18
|
7.2K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Broad, High-Grade Gold Intersected at Monument Gold Project
|
|
followmemax
|
10 |
6.0K |
3 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
10
|
6.0K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Top 20 Holder Report
|
|
followmemax
|
10 |
6.3K |
0 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
10
|
6.3K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Response to ASX Query
|
|
followmemax
|
17 |
8.6K |
5 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
17
|
8.6K
|
5
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Drilling completed at Monument Gold Project
|
|
followmemax
|
13 |
5.1K |
1 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
13
|
5.1K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex Update
|
|
followmemax
|
18 |
5.6K |
4 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
18
|
5.6K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Mernova Update
|
|
followmemax
|
13 |
5.0K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
13
|
5.0K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex Update
|
|
followmemax
|
18 |
5.6K |
1 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
18
|
5.6K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex Update
|
|
followmemax
|
18 |
5.6K |
5 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
18
|
5.6K
|
5
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Mernova Update
|
|
followmemax
|
32 |
9.4K |
1 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
32
|
9.4K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) gives Halucenex’s mushroom harvest update
|
|
followmemax
|
9 |
5.1K |
3 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
9
|
5.1K
|
3
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Numerous Intrusive Gold Targets Identified at Monument
|
|
followmemax
|
77 |
26K |
3 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
77
|
26K
|
3
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) grows revenue and market presence in Q4
|
|
followmemax
|
93 |
36K |
1 |
05/03/22 |
05/03/22 |
ASX - By Stock
|
93
|
36K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
followmemax
|
21 |
6.3K |
2 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
21
|
6.3K
|
2
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
followmemax
|
21 |
6.3K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
21
|
6.3K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Halucenex secures Clinical Trial Authorisation
|
|
followmemax
|
3 |
2.0K |
4 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
3
|
2.0K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Creso Pharma secures commitments to raise $5m
|
|
followmemax
|
22 |
7.4K |
0 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
22
|
7.4K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Creso Pharma secures commitments to raise $5m
|
|
followmemax
|
22 |
7.4K |
1 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
22
|
7.4K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) grows revenue and market presence in Q4
|
|
followmemax
|
93 |
36K |
1 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
93
|
36K
|
1
|
|
ASX - By Stock
|
CPH |
Re:
Creso Pharma (ASX:CPH) grows revenue and market presence in Q4
|
|
followmemax
|
93 |
36K |
1 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
93
|
36K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Monument Gold Project Drilling Program Update
|
|
followmemax
|
53 |
19K |
0 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
53
|
19K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Trading Halt
|
|
followmemax
|
67 |
23K |
0 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
67
|
23K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Trading Halt
|
|
followmemax
|
67 |
23K |
0 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
67
|
23K
|
0
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Trading Halt
|
|
followmemax
|
67 |
23K |
6 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
67
|
23K
|
6
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Trading Halt
|
|
followmemax
|
67 |
23K |
7 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
67
|
23K
|
7
|
|
ASX - By Stock
|
CPH |
Re:
New beginning … No AB
|
|
followmemax
|
32 |
10K |
4 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
CPH |
Re:
Ann: Pause in Trading
|
|
followmemax
|
152 |
63K |
6 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
152
|
63K
|
6
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Upcoming Drilling Program at Monument Gold Project
|
|
followmemax
|
98 |
39K |
1 |
27/05/21 |
27/05/21 |
ASX - By Stock
|
98
|
39K
|
1
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Upcoming Drilling Program at Monument Gold Project
|
|
followmemax
|
98 |
39K |
2 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
98
|
39K
|
2
|
|